Role of BMP-9 in human liver disease
- 7 October 2018
- Vol. 68 (11), 2097-2100
- https://doi.org/10.1136/gutjnl-2018-317543
Abstract
We read with interest the article by Breitkopf-Heinlein et al ,1 investigating the role of bone morphogenetic protein (BMP)-9 in liver regeneration and fibrosis. In mice, the authors demonstrate that BMP-9, a member of the transforming growth factor-β family, is primarily produced by hepatic stellate cells (HSCs) and is a profibrogenic factor. Inhibition or knockout of BMP-9 reduced liver fibrosis, while the recombinant protein increased the proliferation and migration of human HSCs. However, as shown in figure 1H and I of that study, rhBMP-9 did not upregulate fibrosis markers (eg, collagen I, fibronectin, platelet-derived growth factor B and α smooth muscle actin). While BMP-9 expression increased during the activation of primary human HSCs, the authors were unable to demonstrate a correlation between human hepatic BMP-9 expression and liver fibrosis stage from a publicly available microarray dataset. Figure 1 mRNA expression of BMP-9 pathway genes in human liver disease from microarray data. Boxplots showing BMP-9, BMP-10, Alk1 and ACVR2B mRNA in liver from normal and cirrhosis subjects (A), obese subjects with healthy liver and patients with NASH (B), and patients with mild …Keywords
This publication has 4 references indexed in Scilit:
- BMP-9 interferes with liver regeneration and promotes liver fibrosisGut, 2017
- Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells populationOncotarget, 2016
- BMP9 Is a Proliferative and Survival Factor for Human Hepatocellular Carcinoma CellsPLOS ONE, 2013
- Bone morphogenetic protein‐9 induces epithelial to mesenchymal transition in hepatocellular carcinoma cellsCancer Science, 2013